Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,982 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not yet recruiting

Registry of Haploidentical Hematopoietic Stem Cell Transplantation in Adult With Hematologic Disease

NCT06286228

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

Hodgkin's Disease and Chemotherapy Before 40 Years

NCT06116929

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Centre Hospitalier Artois Ternois Arras, France

Hôpital Claude Huriez Lille, France

Hôpital Saint-Philibert Lomme, France

Hôpital Victor Provo Roubaix, France

View Trial Details

Not yet recruiting

A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle CellLymphoma Patients

NCT06255704

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Hematology Department of ShanXi Cancer Hospital Taiyuan, Shanxi, China

View Trial Details

Not yet recruiting

Coagulopathy in Childhood Acute Lymphoblastic Leukaemia

NCT06242353

Conditions: Acute Lymphoblastic Leukemia, Bleeding, Cardiovascular Diseases, +20 more
Locations: Not specified

View Trial Details

Not yet recruiting

Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL

NCT06175702

Conditions: Adult ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations: Not specified

View Trial Details

Not yet recruiting

Response Adapted Incorporation of Tislelizumab Into the Front-line Treatment of Older Patients With Hodgkin lYmphoma

NCT05627115

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT05979857

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Not yet recruiting

Relmacabtagene Autoleucel in Hematologic Malignancies

NCT06142188

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Peking University International Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Selinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCL

NCT06062641

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Ruijin Hospital Shanghai, Shanhai, China

View Trial Details

Not yet recruiting

First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma

NCT06097455

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: CHU Santiago de Compostela Santiago de Compostela, A Coruña, Spain

Hospital Clínic Barcelona Barcelona, Spain

H. Ramon y Cajal Madrid, Spain

H.U. Virgen de la Arrixaca Murcia, Spain

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions